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Psychological stress-related processes are thought to contribute
to the development and progression of type 2 diabetes, but the
biological mechanisms involved are poorly understood. Here, we
tested the notion that people with type 2 diabetes experience
chronic allostatic load, manifest as dynamic disturbances in reactivity
to and recovery from stress across multiple (cardiovascular, neuro-
endocrine, inflammatory, metabolic) biological systems, coupled
with heightened experience of chronic life stress. We carried out
an experimental comparison of 140 men and women aged 50–75 y
with type 2 diabetes and 280 nondiabetic individuals matched on
age, sex, and income. We monitored blood pressure (BP) and heart
rate, salivary cortisol, plasma interleukin (IL)-6, and total cholesterol
in response to standardized mental stress, and assessed salivary cor-
tisol over the day. People with type 2 diabetes showed impaired
poststress recovery in systolic and diastolic BP, heart rate and cho-
lesterol, and blunted stress reactivity in systolic BP, cortisol, choles-
terol, and IL-6. Cortisol and IL-6 concentrations were elevated, and
cortisol measured over the day was higher in the type 2 diabetes
group. Diabetic persons reported greater depressive and hostile
symptoms and greater stress experience than did healthy controls.
Type 2 diabetes is characterized by disruption of stress-related pro-
cesses across multiple biological systems and increased exposure to
life stress. Chronic allostatic load provides a unifying perspective
with implications for etiology and patient management.
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Type 2 diabetes has a heterogeneous pathophysiology in whichβ-cell dysfunction and insulin resistance play pivotal roles (1).
Stress-related factors may contribute to risk of type 2 diabetes
through their impact on inflammatory, metabolic, cardiovascular,
and neuroendocrine regulation (2). Socioeconomic adversity over
the life course predicts type 2 diabetes in later life (3), whereas
stress at work and more general indicators of perceived stress are
associated with future diabetes (4, 5). There appears to be a bi-
directional relationship between type 2 diabetes and depressive
symptoms (6), and people with type 2 diabetes may report greater
social isolation and more limited social support (7).
These diverse associations between stress-related processes
and diabetes are only partly accounted for by lifestyle factors such
as physical inactivity, alcohol consumption, or adiposity, suggest-
ing that direct psychobiological pathways may be involved. A
helpful concept in this regard is allostatic load. Allostasis refers to
the dynamic process of adaptation to environmental challenges
through adjustments in multiple biological systems, including the
hypothalamic–pituitary–adrenocortical (HPA) axis, autonomic
nervous system, and metabolic and immune systems (8). Allostasis
is essential for maintaining homeostasis, but repeated or sustained
stimulation leads to allostatic load, the wear-and-tear that results
from dysregulation of mediating processes. Allostatic load is fre-
quently quantified by measuring a range of biomarkers (e.g., blood
pressure, cortisol, catecholamines, glycated hemoglobin, waist
circumference, cholesterol, inflammatory markers), and allocating
individuals scores based on the number of variables on which
values are elevated compared with the sample distribution (9,
10). Studies relating allostatic load measures with type 2 diabetes
have been inconsistent to date (11, 12). However, another aspect
of allostasis is that it is manifest in modifications of dynamic
responses to challenge, not only in basal measures. Adaptive bio-
logical responses to stress involve brisk increases in activation
(stress reactivity) as the person mobilizes for vigorous activity,
followed by prompt recovery back to baseline levels. McEwen (8)
has noted that high allostatic load disrupts these dynamic bio-
logical responses, resulting in changes in the morphology of
responses, notably impaired poststress recovery and inadequate
biological responses (blunted stress reactivity).
Accordingly, we tested the notion that type 2 diabetes is
characterized by high dynamic allostatic load. We hypothesized
that in response to standardized mental stress, people with type 2
diabetes would show impaired poststress recovery and blunted
stress reactivity in blood pressure (BP), heart rate, cortisol, and
serum cholesterol, together with greater inflammation indexed
by interleukin (IL)-6. We monitored cortisol output in everyday
life by obtaining multiple saliva samples over the day to test
whether people with type 2 diabetes have higher cortisol output
in naturalistic settings. We also measured relevant psychological
variables, conjecturing that people with diabetes would report
more emotional distress, greater stress in their lives, and reduced
psychosocial resources compared with nondiabetic individuals.
Results
We compared 140 men and women aged 50–75 y with type 2
diabetes with 280 nondiabetic individuals matched by age, sex,
and income category. The diabetic participants had better edu-
cation and were less likely to be married than were controls
(Table 1). As expected, glycated hemoglobin (HbA1c), body
mass index (BMI), and waist circumference were greater in the
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diabetes than control groups, and diabetic participants were also
more likely to be smokers. The majority of diabetic participants
were taking oral medications such as metformin, and hyperten-
sive medications were also common. None of the healthy con-
trols were taking any medications apart from a small proportion
of prescribed statins (7.9%).
Physiological Responses to Mental Stress. We tested participants
individually either in the morning or afternoon, monitoring
physiological responses to two standardized mental stress tests.
The proportion of laboratory sessions taking place in the morning
and afternoon did not differ between groups. The mental stress
tasks elicited substantial subjective stress responses, with increases
from 1.50 ± (SD) 0.91 to 4.47 ± 1.56 in the diabetes and 1.42 ±
0.81 to 4.06 ± 1.47 in the no diabetes group. The increase in
subjective stress during tasks did not differ in the two groups
(Table S1). Systolic and diastolic BP and heart rate also rose
during stress tasks, returning toward baseline over the poststress
recovery period. The diabetes group showed a pattern of cardio-
vascular response characteristic of high allostatic load (Fig. 1 and
Table S1). Notably, systolic BP stress reactivity was blunted in the
diabetes compared with control group [adjusted odds of being in
the diabetes group per mmHg increase in reactivity = 0.97, 95%
confidence interval (CI) 0.95–0.99, P = 0.007], whereas recovery
was reduced both at 40–45 min posttress (odds ratio 0.98, 95% CI
0.96–0.99, P = 0.028) and at 70–75 min poststress (odds ratio 0.97,
95% CI 0.95–0.99, P = 0.004). We recorded a similar profile for
diastolic BP and heart rate (Fig. 1); thus, for both variables, stress
reactivity was lower in the diabetes group, and poststress recovery
was impaired (statistical details in Table S1). In addition, the di-
abetes group had lower diastolic BP but higher heart rate than
the healthy control group throughout the stress session (P <
0.001). There were no interactions between sex and diabetic status
in any analyses.
We found that baseline cortisol concentration was substantially
greater in diabetic participants, and cortisol level subsequently fell
across the task period (Fig. 2). Consequently, the groups differed
in cortisol responses to stress, with increases in the control group
and decreases in the diabetes group (Table S1; P < 0.001). The
groups converged over the posttask recovery period. Plasma IL-6
concentration was higher in the diabetes group at baseline (P =
0.014). We recorded increases in IL-6 following stress in both
groups, but the increase was blunted in the diabetes group both at
45 min (P = 0.021) and 75 min (P = 0.028) after tasks. None-
theless, the concentration of IL-6 remained higher in the diabetes
than control groups. The profile of total cholesterol stress re-
sponses was again consistent with high allostatic load (Fig. 2),
wince the rise in cholesterol with stress was blunted in the diabetes
group (adjusted odds of being in the diabetes group per unit mmol
increase in cholesterol = 0.02, 95% CI 0.001–0.27, P = 0.004),
whereas the recovery following stress was reduced (odds ratio
0.018, 95% CI 0.001–0.88, P = 0.043). Sex did not interact with
diabetes status in any of these analyses.
Cortisol Output over the Day. Participants collected five saliva
samples over the day. Both groups showed a typical pattern of
salivary cortisol output, with high levels on waking, an increase
over the first 30 min after waking, and then decreasing levels
through the remainder of the day (Fig. 3). Concentrations were
an average 36% higher in the diabetes than control groups after
adjustment for covariates (P < 0.001), with significant differences
in samples on waking, at 1600–1630, and at 2000–2030.
Stress-Related Psychological Factors. We measured stress-related
psychological factors using standardized questionnaires. Diabetic
participants showed a higher stress profile than controls in terms
of negative emotional responses and greater reported stress ex-
perience (Table 2). They reported more depressive symptoms,
greater hostility, more financial strain, less social cohesion in
their local neighborhoods, less sense of control over their lives,
and less optimism, after adjustment for education and marital
status. Diabetic participants were also more likely to be sepa-
rated, divorced, or widowed than were controls (Table 1). The
two groups did not, however, differ in social support, or in the
proportion that were caring for aging or disabled family mem-
bers. We did not observe any interactions between sex and di-
abetes status in these analyses.
Table 1. Characteristics of diabetes and healthy control groups
Diabetes (n = 140) Healthy control (n = 280) Difference (P)
Men/women 88/52 176/104 1.00
Age, mean ± SD 64.0 ± 6.3 63.7 ± 7.0 0.65
Household income, n (%) 1.00
<£40,000 194 (71.6%) 95 (71.4%) —
≥£40,000 77 (28.4%) 38 (28.6%) —
Education, n (%) 0.001
Less than high school 37 (26.8%) 94 (35.9%) —
High school 14 (10.0%) 77 (29.4%) —
College or higher 87 (63.0%) 91 (34.7%) —
Status, n (%) 0.001
Married 70 (50.0%) 175 (62.9%) —
Single, never married 31 (22.1%) 63 (22.7%) —
Divorced, separated, widowed 39 (27.9%) 40 (14.4%) —
Current smoker, n (%) 20 (14.4%) 18 (6.4%) 0.011
BMI, kg/m2 mean ± SD 30.8 ± 5.72 25.9 ± 3.82 0.001
Waist, cm mean ± SD 105.5 ± 13.5 87.5 ± 12.6 0.001
HbA1c, % mean ± SD 7.25 ± 1.42 5.47 ± 0.53 0.001
HbA1c, mmol/mol 56 ± 15.5 36 ± 5.8 —
Medication, n (%)
Statins 106 (77.9%) 22 (7.9%) 0.001
Oral diabetic medication 109 (80.1%) — —
Insulin, other diabetic medication 15 (11.0%) — —
Aspirin 48 (35.3%) — —
Beta blockers 16 (11.8%) — —
Other hypertensive medication 96 (70.6%) — —
15694 | www.pnas.org/cgi/doi/10.1073/pnas.1410401111 Steptoe et al.
Intercorrelation Between Responses in Different Systems. There
were consistent associations between responses in the different
systems monitored in this study. Thus, cardiovascular (BP and
heart rate) reactions to tasks were negatively correlated with
cortisol output over the day (P < 0.05) and with baseline IL-6
concentration (P < 0.01), while being positively related to cortisol
(P < 0.01) and cholesterol (P < 0.001) responses to mental stress.
Measures of poststress recovery showed similar patterns. Inter-
relationships between biological responses and psychological
characteristics were also present. For example, systolic BP re-
activity was negatively correlated with depressive symptoms, fi-
nancial strain, and hostility, and positively associated with social
cohesion, social support, control over life, and optimism, after ad-
justment for group status (all P < 0.05). Baseline IL-6 concentra-
tion was positively related to depressive symptoms and financial
strain (P < 0.05), and negatively with social support (P = 0.024).
Cortisol responses to acute stress were positively related to social
cohesion (P < 0.05) and social support (P = 0.009), whereas indi-
viduals with greater cortisol output over the day were low in op-
timism (P < 0.001).
Discussion
This study explored the hypothesis that people with type 2 di-
abetes experience chronic allostatic load, manifest in alterations in
dynamic physiological responses to standardized mental stress,
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Fig. 1. Mean systolic BP (Upper), diastolic BP (Center), and heart rate
(Lower) during baseline, task trials, and 40–45 min and 70–75 min posttasks
in the diabetes (red line) and control (black line) groups. BP and heart rate
data are adjusted for education, marital status, BMI, smoking status, beta-
blocker use, and time of testing. P values indicate group differences in stress
reactivity (baseline–task difference) and poststress recovery (task–posttask
differences) as detailed in Table S1. Error bars are SEMs.
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Fig. 2. Mean salivary cortisol (Upper; geometric means), plasma IL-6 (Cen-
ter; geometric means), and total cholesterol (Lower) in the diabetes (red
line) and control (black line) groups. Cortisol sampled at baseline, immedi-
ately after tasks, and 20, 45, and 75 min later. Values are adjusted for ed-
ucation, marital status, BMI, smoking status, use of statins, and time of
testing. The P value indicates group differences in stress reactivity. IL-6 was
adjusted for education, marital status, BMI, smoking, and time of testing;
P values indicate group differences in stress reactivity. Total cholesterol was
adjusted for education, marital status, BMI, smoking, aspirin, use of statins,
and time of testing. P values indicate group differences in stress reactivity
(baseline–task difference) and poststress recovery (task–posttask difference).
Error bars are SEM.
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higher cortisol output over the day, and greater psychological
distress and experience of chronic life stress, in comparison with
age, sex, and income matched controls. We found that poststress
recovery was attenuated in the diabetes group in systolic and di-
astolic BP, heart rate, and total cholesterol, together with blunted
stress reactivity in BP, heart rate, cortisol, and cholesterol con-
centration. These effects were independent of covariates including
medication and were evident in both men and women. The acute
increases in cholesterol concentration are likely to be due in part
to reductions in blood volume following stress, leading to greater
hemoconcentration. Plasma IL-6 concentration was higher in
people with type 2 diabetes, so that although the increases fol-
lowing mental stress were smaller than those of controls, absolute
levels remained higher. The type 2 diabetes group had higher
baseline cortisol than controls in the laboratory, together with
heightened cortisol output throughout the day. We also found that
people with type 2 diabetes had more depressive and hostile
symptoms, and reported greater chronic stress in terms of finan-
cial and neighborhood strain.
The multisystem measures of allostatic load described in the
literature typically involve measures taken under resting con-
ditions and include several components of the metabolic syn-
drome such as elevated BP, triglycerides, and waist circumference
(13), so it is surprising that the concept has not been successfully
applied to type 2 diabetes. One study of middle-aged Puerto
Ricans living in Boston showed that greater allostatic load was
associated with increased risk of diabetes and other chronic con-
ditions (12), but another investigation focusing specifically on
diabetes failed to find that the components of allostatic load
clustered reliably in people with diabetes (11).
Our results suggest that attention to the dynamic aspects of
allostatic load may be fruitful. Our systematic review of published
literature found no previous studies that have examined the dy-
namic responses to mental stress across multiple biological systems
in type 2 diabetes. One small study showed that systolic BP
responses to a mental arithmetic task were greater in diabetes than
healthy groups, but it involved an inappropriate comparison group
and did not use continuous measures of BP (14). Three studies
have compared diurnal salivary cortisol profiles in people with and
without type 2 diabetes: Two reported smaller cortisol responses
to waking in diabetic participants (15, 16) and one a flatter slope
over the day (17), but differences in cortisol output over the day
have been inconsistent. We observed striking elevations in cortisol
at baseline and in everyday life in people with type 2 diabetes,
and elevated cortisol has been implicated in the development of
the metabolic syndrome (18). Heightened cortisol output is also
thought to be involved in the development of obesity, but we
controlled statistically for BMI in these analyses. Blunted cortisol
stress reactivity may have a permissive effect on IL-6 in type 2
diabetes. The high IL-6 concentration is likely related to the role of
inflammation in type 2 diabetes, promoting insulin resistance and
dyslipidemia by inhibiting enzymes involved in fatty acid oxidation,
down-regulating the expression of genes involved in insulin-stim-
ulated glucose transport and lipid uptake in adipocytes (19, 20).
Apart from heightened dynamic allostatic load, one alterna-
tive explanation for our results is that people with diabetes were
less stressed by the behavioral challenges, so they produced
smaller biological responses; however, the subjective ratings in-
dicate that the diabetes and control groups were stressed to the
same extent by the tasks. A second possibility is that effects were
confounded by the multiple medications used to control di-
abetes. These medications may have contributed to the low
baseline levels of diastolic BP and total cholesterol observed in
the diabetes group (Figs. 1 and 2), but we took account statis-
tically of medications that had associations with biological stress
responses. Third, it is conceivable that the differences in BP and
heart rate were early manifestations of neuropathy in people
with diabetes, although none had clinical signs of cardiac auto-
nomic neuropathy (21).
Our observation that depressive symptoms were elevated in
people with type 2 diabetes replicates previous research (6) and
is important in light of the evidence that depression in diabetic
populations is associated with accelerated cognitive decline (22)
and increased mortality risk (23). It is interesting that all of the
psychosocial measures except for caregiving indicated greater
stress among people with diabetes than controls. The result is
a profile of psychosocial adversity in the type 2 diabetes group
likely to promote heightened allostatic load.
Measures of allostatic load have been criticized for bringing
together an arbitrary set of biomarkers, assuming that extreme
values load on an underlying unitary construct. However, recent
factor analytic studies indicate that a single common factor
underlies variation across autonomic, neuroendocrine, inflam-
matory, and metabolic processes (13, 24). The intercorrelations
between responses in the different biological systems, and be-
tween biological responses and psychosocial factors, provide
further support for the value of this approach.
The study was cross-sectional, so no causal conclusions can be
drawn. It is possible that heightened allostatic load precedes
the development of type 2 diabetes and is a mechanism through
which psychosocial factors contribute to diabetes risk. There
are direct effects of inflammation on β cells (1), and heightened
inflammation predicts diabetes onset (25). Autonomic and glu-
cocorticoid regulation are also implicated in central fat de-
position and the metabolic syndrome (26, 27), so they may
contribute to the development of diabetes. Studies of heightened
dynamic allostatic load in people with insulin resistance but no
diabetes would throw light of this pathway. The alternative is
that allostatic load is a manifestation of diabetes that is sec-
ondary to the abnormalities of glucose metabolism. The cardio-
vascular, neuroendocrine, and inflammatory responses we observed
may be significant for the broader health consequences of diabetes.
Disturbances of cortisol regulation are apparent in coronary
heart disease and depression (28, 29), and it has been argued
that glucocorticoids may contribute to the development of cog-
nitive impairment in people with diabetes (30). Chronic systemic
inflammation is also involved in cardiovascular disease, de-
mentia, and depression (31, 32). Our results are consistent with
the possibility that some of the comorbidities of type 2 diabetes
arise from the disruption of the multiple systems involved in
allostatic load rather than being direct consequences of im-
paired glucose regulation.
The dynamic aspects of multisystem dysregulation in allostatic
load have not been studied prospectively in relation to long-term
health outcomes. However, other measures of allostatic load pre-
dict future mortality and functional decline in older people (9).
Individual components such as reduced cardiovascular poststress
recovery, blunted stress reactivity, and increased IL-6 during acute
stress are also associated with future adverse health outcomes (33).
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Fig. 3. Mean salivary cortisol sampled on waking, 30 min after waking, and in
the morning (1000–1030), afternoon (1600–1630), and evening (2000–2030) in
the diabetes (red line) and control (black line) groups. Values are adjusted for
education, marital status, BMI, smoking status, oral diabetic medication, and
beta-blocker use. Error bars are SEM.
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In addition to the cross-sectional design, other limitations of this
study are that the diabetes group was more ethnically diverse than
the control group, and that the assessment of stress responses
was carried out over a single session. Further, we did not measure
glucose and insulin responses across the mental stress session.
Nonetheless, our observations provide fresh evidence to link
epidemiological studies implicating stress-related processes
with biological dysfunction in type 2 diabetes. The patterns
of cardiovascular and cholesterol responses exemplify the dis-
turbances of reactivity and recovery noted in McEwen’s model of
allostatic load (8). It has been posited that high allostatic load
leads to prolonged responses due to delayed shutdown of physi-
ological reactivity, so poststress recovery is impeded. Blunted re-
activity may also occur, resulting in compensatory hyperactivity in
other mediating pathways. The allostatic load concept synthesizes
diverse findings concerning stress-related dysregulation across
cardiovascular, neuroendocrine, metabolic, and inflammatory
systems. Our findings highlight the importance of moving beyond
glucose regulation to address a range of disturbances across
multiple systems. Although individual pathways can be targeted
by pharmacotherapy, the allostatic approach implies that systems
interact in a dynamic fashion. Interventions that affect both brain
and body are likely to be particularly beneficial. Two promising
candidates are physical activity and social integration, both of
which are implicated in diabetes (34). Development of the
allostatic approach to type 2 diabetes may open new avenues for
pharmacological and social-behavioral approaches to manage-
ment and prevention.
Materials and Methods
Participants. One hundred and forty individuals with type 2 diabetes were
recruited from diabetic outpatient and primary care clinics in the London area
with an invitation to take part in an investigation of how people with type
2 diabetes respond to stress. We limited enrollment to patients without
a history or previous diagnosis of coronary heart disease (CHD), inflamma-
tory diseases, allergies or mood disorders, and no evidence of autonomic
neuropathy. Respondents included 88 men and 52 women aged 50–75 y.
The healthy controls in this analysis came from the Heart Scan Study,
a subsample of the Whitehall II epidemiological cohort recruited between
2006 and 2008 to investigate socioeconomic and psychosocial factors,
physiological stress responsivity, and subclinical coronary artery disease (35).
Volunteers were invited to take part in a study of how people respond to
stress, and a sample of 543 men and women of white European origin with
no history or objective signs of CHD, no previous diagnosis or treatment for
hypertension, diabetes, inflammatory diseases, or allergies was recruited.
The absence of diabetes was confirmed by low HbA1c levels (≤6.5%, or
48 mmol/mol) and negative oral glucose tolerance tests over the previous
20 y. We matched every person with diabetes as closely as possible by age,
sex, and income category with two healthy controls, so the 140 diabetic
respondents were compared with 280 nondiabetic individuals. All partic-
ipants gave full informed consent, and ethical approval was obtained from
the National Research Ethics Service.
Mental Stress Testing. We tested participants individually either in the
morning or afternoon. BP and heart rate were monitored continuously by
using a Finometer, and a venous cannula was inserted for blood collection.
Baseline blood and saliva samples were collected, and subjective stress ratings
were obtained on a seven-point scale from 1 = no stress to 7 = maximum
stress. We then administered two 5-min behavioral tasks in random order.
These were a computerized version of the Stroop color-word interference
task and a mirror drawing task as described (35). These tasks were originally
designed as tests of cognitive function, but were adapted to provide mod-
erately stressful behavioral challenges. Subjective stress, blood, and saliva
samples were taken immediately after tasks. The posttask recovery period
lasted 75 min, with further saliva samples at 20, 45, and 75 min and addi-
tional blood samples and stress ratings at 45 and 75 min. Blood samples were
centrifuged immediately at 400 × g for 10 min at room temperature and
plasma was separated and stored at −80 °C until analysis.
Cortisol Output over the Day. Participants collected five saliva samples over
a single day by using Salivettes (Sarstedt), at waking, 30 min later, and then
within three 30-min time windows in the morning (1000–1030), afternoon
(1600–1630) and evening (2000–2030). They were told not to eat, drink tea
or coffee, or smoke in the 30 min before each sample was collected. Viola-
tions of the protocol and sample timing were recorded in a log. Satisfactory
data were obtained from 119 diabetic and 236 nondiabetic participants.
Biological Measures. Plasma IL-6 was assayed by using a Quantikine high
sensitivity two-site ELISA (R&D Systems). The sensitivity of the assay ranged
from 0.016 to 0.110 pg/mL, and the intraassay and interassay coefficient of
variations was 7.3% and 7.7% respectively. Cortisol was assessed from saliva
samples by using a time resolved immunoassay with fluorescence detection
at the University of Dresden, Germany. Total cholesterol was measured in
a centrifugal analyzer by enzymatic colorimetric methods. Plasma IL-6 was
assayed from all four blood samples, HbA1c from the baseline sample alone,
and total cholesterol from the baseline, task, and 45 min posttask samples.
Psychological Measures. We measured two stress-related psychological char-
acteristics, depressive symptoms and hostility, using the Center for Epidemio-
logic Studies Depression Scale and the 10-item Cook–Medley cynical hostility
scale, respectively. Stress exposure was assessed in terms of financial strain and
neighborhood social cohesion with a measure of collective efficacy (36). We
also noted whether the participant was a caregiver for an elderly or disabled
relative or friend. Participants rated their sense of control over their lives in
general by using a six-point scale from 1 = very low to 6 = very high, whereas
social support and optimism were assessed with standardized measures (37,
38). The Cronbach α was satisfactory for all psychological measures (>0.75).
Other Measures. Participants reported household income in bands that were
subsequently reduced to lower (<£40,000) and higher (≥£40,000) income
categories. Education was categorized into less than high school, high school
or equivalent, and college or higher. Medication in the diabetes group was
categorized into oral diabetic medication (metformin), insulin and other
injected diabetic medication, aspirin, beta blockers, other hypertensive
medication (ACE inhibitors, calcium channel blockers), and statins.
Statistical Analysis.We computedmean systolic BP, diastolic BP, and heart rate
for five periods: baseline (the last 5 min of the 30-min baseline period), the two
task trials combined, and poststress recovery minutes 40–45 and 70–75. We
conducted repeated measures analysis of variance to assess patterns of change
across the session, with group and sex as between-person factors and trial
as the within-person factor. Because this study was a matched case-control
Table 2. Psychosocial factors in the diabetes and healthy control groups
Diabetes* Healthy control* Odds of diabetes† (95% C.I.) P
Depression symptoms 11.86 ± 8.9 6.47 ± 6.6 1.16 (1.11–1.22) 0.001
Hostility 3.78 ± 2.8 2.72 ± 2.4 1.20 (1.08–1.37) 0.001
Financial strain 84 (71.2%) 122 (43.7%) 1.38 (1.24–1.53) 0.001
Social cohesion 9.83 ± 5.5 11.62 ± 4.6 0.91 (0.86–0.96) 0.001
Caregiver 24 (17.1%) 37 (13.2%) 1.37 (0.74–2.56) 0.32
Sense of control 3.29 ± 1.6 3.92 ± 1.4 0.77 (0.65–0.91) 0.002
Optimism 14.4 ± 4.3 15.5 ± 3.8 0.91 (0.86–0.96) 0.002
Social support 25.7 ± 7.1 26.3 ± 5.4 0.99 (0.95–1.04) 0.72
*Mean ± SD, or n (%).
†Odds of being in the diabetes group per unit change in the independent variable, adjusted for education and
marital status.
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design, analysis of variance and general estimating equation models were not
appropriate for comparisons between groups. Instead, we analyzed differ-
ences between groups in stress reactivity and stress recovery by using condi-
tional logistic regression, which takes account of the matched case-control
design (39). We computed difference scores between tasks and baseline (for
stress reactivity) and differences between tasks and recovery measures (for
recovery analyses), and entered these along with covariates into regressions on
group (diabetes or control) membership. Results are presented as adjusted
odds of being in the diabetes as opposed to the control group per unit change
in the predictor variable, with 95% confidence intervals (95% CI). A value >1
indicates that larger values of the predictor are associated with increased odds
of being in the diabetes group, while values <1 indicate that larger values are
associated with reduced odds of being in the diabetes group. Stress responses
in IL-6 are delayed in comparison with other measures, so we assessed re-
activity as differences between values recorded at 45 min and 75 min com-
pared with baseline. Poststress recovery in cardiovascular measures, cortisol,
and cholesterol was measured by using difference scores between task and
recovery period means. We log transformed cortisol and IL-6 before analysis
because of positive skews in the distribution, and geometric means are pre-
sented in Results. Cortisol output over the day was quantified as area under
the curve (40). There were 28 (20%) ethnic minority participants in the
diabetes group, but adding ethnicity as a factor to the analyses did not alter
the pattern of results, so it is not included in the models described here.
All analyses of physiological data were adjusted for BMI and smoking
status, because these variables are known to influence stress responses.
Time of day of stress testing was included as a covariate, because profiles of
response to stress may vary across the day. We also adjusted for education
and marital status because of differences between groups, because these
factors might affect stress responsivity. We selected medication covariates
by testing for associations between medication status and stress responses
within the diabetes group. Thus, BP and HR analyses were additionally
adjusted for use of beta blockers in addition to education, marital status,
BMI, and smoking; cortisol analyses for statins; and cholesterol responses
for use of statins and aspirin. Psychological differences between groups
were analyzed by using conditional logistic regression adjusted for education
and marital status. We also explored interrelationships between cardiovascular
and other biological responses, and between biological responses and psy-
chological factors, by computing product–moment correlations.
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